Alternative Investment Funds (AIF)
Compare Schemes

Accuracap - AlphaGen Next vs Kotak India Renaissance Fund-I

Accuracap - AlphaGen Next
Kotak India Renaissance Fund-I
Add Scheme
Growth of ₹1 Crore
Accuracap - AlphaGen Next
Kotak India Renaissance Fund-I
Return for the risk
3 yrs return
0%
5%
10%
15%
Nifty 500 · 10.7%
0%
10%
20%
Volatility • 3 yrs deviation
1 Month
0.90%
4.52%
6 Months
5.00%
8.26%
1 Year
1.70%
4.50%
3 Years
7.90%
10.05%
5 Years
6.00%
—
Since Inception
9.60%
10.10%
Fund Age
7 yrs 7 mo
4 yrs 5 mo
AUM
—
₹60.73 Cr
Alpha – 1 Year
−0.30%
4.93%
Alpha – 3 Years
−2.80%
1.48%
Information Ratio – 3 Years
-0.63
0.19
Volatility – 1 Year
13.09%
15.08%
Volatility – 3 Years
13.74%
14.98%
Beta – 1 Year
0.71
0.81
Beta – 3 Years
0.80
0.93
Sharpe Ratio – 1 Year
-0.22
-0.02
Sharpe Ratio – 3 Years
0.23
0.35
Worst Rolling Year
5.51%
7.06%
Value at Worst Rolling Year
₹1.06 Cr
₹1.07 Cr
Deepest Drawdown
−20.17%
−22.08%
Recovery Period
Not yet recovered
Not yet recovered
1-Year Rolling Windows Positive
100.00%
100.00%
Median Rolling Year
11.91%
11.56%
5-Year Rolling Windows Positive
100.00%
—
Market-Cap Mix
L 72% · M 14% · S 13%
L 31% · M 22% · S 40%
Number of Stocks
—
—
Portfolio P/E
—
—
Top 5 Holdings
Polycab India Ltd · 6.57%
TVS Motor Company Ltd · 4.70%
Apollo Hospitals Enterprise Ltd · 4.65%
Neuland Laboratories Ltd · 4.46%
Hitachi Energy India Ltd · 4.43%
Shriram Finance Ltd · 6.87%
Jubilant Ingrevia Ltd · 5.84%
Fortis Healthcare Ltd · 5.16%
Emcure Pharmaceuticals Ltd · 5.09%
ICICI Bank Ltd · 4.96%
Top Sectors
—
—
Fixed Fee
2.50% / yr
—
Performance Fee / Plan
Fixed Plan
—
Exit Load (Y1 / Y2 / Y3)
—
—
Let's start a
conversation
  • Compare this PMS against 3,000+ others with our research desk
  • Build a long-term portfolio around your goals, not a one-off buy
  • Experts with decades of experience.
Private. Personal. No obligation.
We will only use these details to contact you about this enquiry. No spam.
Start a conversation
Share a few details and an expert will reach out.
We will only use these details to contact you about this enquiry. No spam.